Cannabinoid (CB) receptor agonists are of growing interest as targets for anti-seizure therapies. Here we examined the effect of systemic administration of the CB receptor agonist WIN 55. 212-2 (WIN) against audiogenic seizures (AGSs) in the Genetically Epilepsy Prone Rat (GEPR)-3 strain. and against seizures evoked focally from the Area Tempestas (AT). https://countryscenesaddleryandpetsuppliers.shop/product-category/western-saddle-pad/